Can a patient taking Eliquis (apixaban) safely use valerian root to calm nerves?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can a Patient on Eliquis Take Valerian Root?

Yes, a patient taking Eliquis (apixaban) can safely continue valerian root for anxiety or sleep, as valerian does not have clinically significant interactions with anticoagulants and may be safely continued even in the perioperative period.

Evidence-Based Recommendation

The most authoritative guidance comes from the 2021 Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement, which specifically addresses valerian in the context of anticoagulation 1. Unlike many other herbal supplements that require discontinuation before surgery due to bleeding risk, valerian is explicitly recommended to "consider continuing" even in high-risk surgical settings 1. The consensus notes that valerian "appears to be a safe supplement" with no objective evidence of significant drug interactions with CNS depressants or anticoagulants 1.

Key Safety Considerations

No Anticoagulant Interaction

  • Valerian does not affect platelet function or coagulation pathways
  • Unlike supplements such as St. John's wort (which induces CYP3A4), turmeric (which inhibits platelet aggregation), or ginkgo (which increases bleeding time), valerian has no documented mechanism for interfering with apixaban's anticoagulant effect 1
  • The FDA label for Eliquis advises patients to inform their doctor about "all medicines including herbal supplements" but does not specifically contraindicate valerian 2

Apixaban's Drug Interaction Profile

Apixaban is primarily affected by strong dual inhibitors or inducers of both CYP3A4 and P-glycoprotein (P-gp) 3. Valerian does not significantly affect either of these pathways, distinguishing it from problematic herbs like St. John's wort.

Clinical Caveats

Monitor for Sedation

While valerian doesn't interact with anticoagulation, be aware that:

  • Valerian is used primarily for insomnia and anxiety 4
  • If the patient takes other CNS depressants (benzodiazepines, sedatives), there is theoretical potential for additive sedation 5
  • One case report described enhanced benzodiazepine effects when valerian was combined with lorazepam, causing tremor and dizziness 5

Quality and Efficacy Concerns

  • A 2020 systematic review found that valerian's effectiveness for sleep is inconsistent, possibly due to variable extract quality 4
  • The SPAQI consensus notes "no objective benefit for sleep latency or quality" despite its widespread use 1
  • Whole root/rhizome preparations may be more reliable than standardized extracts 4

When to Avoid

Do not use valerian if the patient:

  • Has active bleeding (this is an Eliquis contraindication, not valerian-specific) 2
  • Is scheduled for neuraxial anesthesia within 24 hours (Eliquis timing concern) 2
  • Has severe liver dysfunction (affects both apixaban metabolism and herbal supplement clearance)

Practical Approach

You can reassure the patient that valerian root is safe to use with Eliquis. However:

  1. Document the use in the medical record, as the FDA label requests notification of all supplements 2
  2. Set realistic expectations about efficacy, as evidence for valerian's anxiolytic effects is modest 4
  3. Screen for other medications that might interact with valerian (particularly benzodiazepines or other sedatives) 5
  4. Ensure proper Eliquis dosing continues (5 mg twice daily, or 2.5 mg twice daily if patient meets dose-reduction criteria: age ≥80, weight ≤60 kg, or creatinine ≥1.5 mg/dL) 2

The combination poses no increased bleeding risk and does not require any adjustment to anticoagulation monitoring or dosing.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.